# EDGAR Filing Document

**Accession Number:** 0000793524
**File Stem:** 0001493152-26-007368
**Filing Date:** 2026-2
**Character Count:** 41360
**Document Hash:** a9c706e5528b3c27be780a3a7ef9ae44
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-007368.hdr.sgml**: 20260218

**ACCESSION NUMBER**: 0001493152-26-007368

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20260218

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260218

**DATE AS OF CHANGE**: 20260218

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RESEARCH FRONTIERS INC
- **CENTRAL INDEX KEY:** 0000793524
- **STANDARD INDUSTRIAL CLASSIFICATION:** PATENT OWNERS & LESSORS [6794]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 112103466
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-14893
- **FILM NUMBER:** 26650373

**BUSINESS ADDRESS:**
- **STREET 1:** 240 CROSSWAYS PARK DR
- **CITY:** WOODBURY
- **STATE:** NY
- **ZIP:** 11797-2033
- **BUSINESS PHONE:** 5163641902

**MAIL ADDRESS:**
- **STREET 1:** 240 CROSSWAYS PARK DR
- **CITY:** WOODBURY
- **STATE:** NY
- **ZIP:** 11797-2033

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): February 18, 2026

**RESEARCH FRONTIERS INCORPORATED**

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

delaware 000-14893 11-2103466 <br> (STATE OR OTHER JURISDICTION (COMMISSION (IRS EMPLOYER <br> OF INCORPORATION) FILE NUMBER) IDENTIFICATION NO.)

240 CROSSWAYS PARK DRIVE

WOODBURY, new york 11797-2033

(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES AND ZIP CODE)

REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (516) 364-1902

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) [240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act

---

| | | |
|:---|:---|:---|
| Title of each Class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.0001 per share | REFR | The NASDAQ Stock Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01. Entry Into a Material Definitive Agreement**

On February 18, 2026, the Company entered into subscription agreements with a group of private accredited investors, which included family members of a director of the Company, as well as the owner of a licensee of the Company licensed to produce SPD-SmartGlass products including SPD-SmartGlass products for the retrofit architectural glass market.

The investors purchased 1.1 million shares of common stock of the Company at a price of $1.00 per share (which represents the closing market price of the Company's common stock on February 13, 2026 which was the date that the transaction was agreed to). The Company will receive $1.1 million in proceeds from the sale of common stock to the investors. For each share received, the investor also received one warrant (expiring on February 28, 2031) to purchase one share of common stock at an exercise price of $1.10 for warrant exercises occurring on or before February 28, 2027, $1.20 for warrant exercises occurring between March 1, 2027 through February 29, 2028, $1.30 for warrant exercises occurring between March 1, 2028 through February 28, 2029, and $1.50 for warrant exercises occurring after February 28, 2029 and prior to the expiration of the warrants.

The shares were issued to the investors in a private placement and, along with the shares issued in connection with the exercise of any warrants in the future, are not registered and therefore currently subject to at least a six month holding period by the investor. Research Frontiers is filing the related transaction documents as Exhibits 1.1 and 1.2 to this current report on Form 8-K.

This report may include statements that may constitute "forward-looking" statements as referenced in the Private Securities Litigation Reform Act of 1995. Those statements usually contain words such as "believe", "estimate", "project", "intend", "expect", or similar expressions. Any forward-looking statements are made by the Company in good faith, pursuant to the safe-harbor provisions of the Act. These forward-looking statements reflect management's current views and projections regarding economic conditions, industry environments and Company performance. Factors, which could significantly change results, include but are not limited to: sales performance, expense levels, competitive activity, interest rates, changes in the Company's financial condition and several business factors. Additional information regarding these and other factors may be included in the Company's quarterly 10-Q and 10K filings and other public documents, copies of which are available from the Company on request. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this report.

The information in this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

**Item 9.01. Financial Statements and Exhibits.**

(c) Exhibits.

1.1 [Form of Subscription Agreement](ex1-1.htm) <br> 1.2 [Form of Warrant Agreement.](ex1-2.htm) <br> 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **RESEARCH FRONTIERS INCORPORATED** | **RESEARCH FRONTIERS INCORPORATED** |
|  | */s/ Joseph M. Harary&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;* |
| By: | Joseph M. Harary |
| Title: | President and CEO |

---

Dated: February 18, 2026

## Exhibit 1.1

**Exhibit 1.1**

**RESEARCH FRONTIERS INCORPORATED**

**SUBSCRIPTION AGREEMENT**

February 16, 2026

Research Frontiers Incorporated

240 Crossways Park Drive

Woodbury, New York 11797-2033

Attention: Joseph M. Harary, President and CEO

Gentlemen:

This Subscription Agreement is made by and between Research Frontiers Incorporated, a Delaware corporation (the "Company"), and the undersigned (the "Subscriber"), in connection with the offering (the "Offering") of certain shares of common stock of the Company, $.0001 par value per share (the "Shares") and related stock purchase warrants. For every one (1) Share purchased by the Subscriber, hereunder, the Subscriber shall also receive one (1) warrant expiring on February 28, 2031 (the "Warrant") to purchase one share of common stock at the exercise price per warrant under the terms contained in the attached form of Warrant Agreement which shall evidence the Warrant being issued to the undersigned.

The Shares and the Warrants issuable hereunder are referred to as the "Securities". The Offering and sale of the Securities are being made pursuant to an exemption from registration under the Securities Act of 1933, as amended (the "Act"). The undersigned agrees on behalf of itself or any of its affiliates that in the event the Company does not have an effective registration statement, there is no circumstance that would require the Company to net cash settle the Warrants or any warrants previously issued to the undersigned or any affiliate of the undersigned.

A. <u>Subscription</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Subscriber hereby irrevocably subscribes to purchase the number of Shares listed on the signature page hereof at a price per Share equal to the greater of (A) $1.00/share or (B) the consolidated closing bid price for Research Frontiers in effect immediately before this subscription agreement is countersigned by Research Frontiers plus $0.03 (the price per share multiplied by the number of shares being purchased hereunder being the "Subscription Price"). For each one (1) Share purchased, the Subscriber shall also receive one (1) Warrant. No fractional Warrants shall be issued and the total number of Warrants issuable to the Subscriber hereunder shall be rounded down to the nearest whole number of Warrants.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. As part of the subscription, Subscriber herewith tenders:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) two
 copies of this Agreement duly completed and executed by Subscriber.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) payment
 of the Subscription Price made by wire transfer of immediately available funds in U.S. Dollars
 to the account of Research Frontiers Incorporated at JP Morgan Chase Bank, 6040 Tarbell Road,
 Syracuse, New York 13206, Account No.: 880-834-155, ABA Wire Code No.: 021 000 021, SWIFT
 CODE: CHASUS33.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Subscriber understands and agrees that the subscription contained herein shall not be deemed binding upon the Company until it is accepted by the Company and that the subscription may be rejected by the Company in its sole discretion for any reason. Subscriber further acknowledges and agrees that, subject to applicable law, this subscription is irrevocable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. If this subscription is not accepted by the Company, all Subscription Funds and the documents herewith delivered to the Company by Subscriber will be returned promptly to Subscriber. In such event, all proceeds theretofore received by the Company from the Subscriber will be refunded in full, without interest or deduction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. If this subscription is accepted by the Company, then the Company shall promptly countersign both copies of this Agreement and return one fully executed copy to Subscriber. All Subscription Funds of Subscriber shall be applied to the purchase of the Shares which Shares shall then be delivered to the Subscriber in certificate form. In addition, the Company shall deliver to the Subscriber a Warrant Agreement representing the Warrants to be issued to the Subscriber hereunder. All Subscription Funds of Subscriber shall be used for research and development, working capital, acquisitions, and for general corporate purposes in such amounts as the Company, in its discretion, deems appropriate. The Company may also, in its discretion, apply such Subscription Funds towards the development of products using the Company's technology through an investment by the Company in one or more joint ventures with third parties set up for such purposes, or may directly apply Subscription Funds to product development.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. Certificates representing Shares issued hereunder shall be stamped or otherwise imprinted with a legend substantially in the following form (in addition to any legend required under any applicable state securities laws):

THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS THERE IS A REGISTRATION STATEMENT THEN IN EFFECT COVERING SUCH SHARES OR AN EFFECTIVE EXEMPTION FROM SUCH REGISTRATION OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT UNDER THE CIRCUMSTANCES REGISTRATION IS NOT NECESSARY.

Provided, however, that if the issuance of the Shares at some point in the future are subject to an effective registration statement pursuant to Section 5 of the Securities Act of 1933, as amended, certificates representing the Shares shall not bear any restrictive legend.

B. <u>Investor Representations</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. In order to induce the Company to accept the subscription hereby made, and recognizing that the Company will be relying thereon in determining whether to accept such subscription, Subscriber hereby represents and warrants to the Company as of the date of this subscription as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Subscriber
 understands that the Securities are a highly speculative investment and that Subscriber's
 financial situation is such that (i) Subscriber can afford to hold the Securities for an
 indefinite period of time and to sustain a complete loss of its investment, and (ii) Subscriber
 has adequate means of providing for Subscriber's current needs and possible contingencies
 and has no need for liquidity in this investment in the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Subscriber
 has received and carefully read the Company's Proxy Statement dated April 30, 2025;
 the Company's Annual Report on Form 10-K for the fiscal year ending December 31, 2024;
 and the Company's Quarterly Reports on Form 10-Q for the fiscal quarters ending March
 31, 2025, June 30, 2025 and September 30, 2025, and the Company's Current Reports on
 Form 8-K and all other reports filed with the Commission during the past two years (collectively,
 the "Reports"). The Company has also made available to Subscriber all other documents
 and information that Subscriber has requested relating to an investment in the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) By
 virtue of Subscriber's knowledge and experience in financial and business matters,
 Subscriber is capable of evaluating the merits and risks of an investment in the Securities.
 Subscriber has taken full cognizance of and understands all the risk factors related to the
 purchase of the Securities, including, but not limited to, those set forth in the Company's
 reports and registration statements filed with the Securities and Exchange Commission.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Subscriber
 understands that the Securities are being offered and sold to Subscriber in reliance on specific
 provisions of federal and state securities laws of the United States of America and that
 the Company is relying upon the truth and accuracy of the representations, warranties, agreements,
 acknowledgments and understandings of Subscriber set forth herein in order to determine the
 applicability of such provisions. Accordingly, Subscriber agrees to notify the Company of
 any events which would cause the representation and warranties of Subscriber to be untrue
 or breached at any time after the execution of this Agreement by Subscriber. The Subscriber
 acknowledges, represents and agrees that no action has been or will be taken in any jurisdiction
 outside the United States by the Company that would permit an offering of the Securities,
 or possession or distribution of offering materials in connection with the issue of the Securities
 in any jurisdiction outside the United States where action for that purpose is required.
 Each Subscriber outside the United States will comply with all applicable laws and regulations
 in each foreign jurisdiction in which it purchases, offers, sells or delivers Securities
 or has in its possession or distributes any offering material, in all cases at its own expense.
 No party has been authorized to make, and has not made, any representation or use of any
 information in connection with the issue, placement, purchase and sale of the Securities,
 except as set forth or incorporated by reference in the Base Prospectus or the Prospectus
 Supplement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Subscriber
 is an "accredited investor" as defined in Rule 501 promulgated under the Securities
 Act of 1933, as amended.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Subscriber,
 and any person acting in concert with Subscriber, currently has no existing short position,
 and during the last 20 trading days had no short position, with respect to the common stock
 of the Company and agrees not to enter into any short sales or other hedging transactions
 with respect to any securities of the Company at any time after the execution of this Agreement
 by Subscriber and so long as any Securities are held by or for the benefit of Subscriber
 or its affiliates or persons acting in concert with Subscriber or its affiliates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) In
 evaluating the suitability of an investment in the Company, Subscriber has not relied upon
 any representations or other information (whether oral or written) from the Company, and
 its officers, directors, agents, employees or representatives, other than as set forth in
 the Reports. With respect to tax and other economic considerations of this investment, Subscriber
 is not relying for advice on the Company, or any officers, directors, employees or agents
 thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Subscriber
 understands that Subscriber's subscription hereunder is not transferable or assignable,
 either before or after acceptance thereof by the Company, and that Securities will only be
 issued in the name of Subscriber and may not be assigned without the consent of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The
 Securities will be acquired for Subscriber's own account, for investment purposes only,
 and not with a view to distribution, assignment or resale to others.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) Subscriber
 understands that no federal or state agency has made any finding or determination as to the
 fairness of this offering or any recommendation or endorsement relating to the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) The
 address heretofore provided to the Company by the Subscriber is the true and correct residence
 of the Subscriber, and Subscriber has no present intention of becoming a resident of any
 other state or jurisdiction. (If a corporation, trust or partnership, the Subscriber has
 its principal place of business at the address set forth below and was not organized for
 the specific purpose of acquiring the Securities).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) Subscriber
 acknowledges that any delivery of offering materials relating to the Securities prior to
 the determination by the Company of Subscriber's suitability as an investor shall not
 constitute an offer of Securities until such determination of suitability shall be made.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) This
 Agreement has been duly authorized, validly executed, and delivered on behalf of Subscriber
 and is a valid and binding agreement enforceable in accordance with its terms, subject to
 general principles of equity and to bankruptcy or other laws affecting the enforcement of
 creditors' rights generally.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) Subscriber
 has not taken any action that would cause the Company to be subject to any claim for commission
 or other fee or remuneration by any broker, finder, or other person and Subscriber hereby
 indemnifies the Company, and its officers, directors, shareholders and representatives, and
 each of their affiliates against any such claim caused by the actions of Subscriber or any
 of its employees or agents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) Subscriber
 will not make any offers or sales of the Securities other than pursuant to a registration
 statement under the Securities Act or pursuant to an exemption from registration under the
 Securities Act. The Subscriber will comply with applicable prospectus delivery requirements
 under the Exchange Act, and with all applicable securities laws upon resale of the Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p) Subscriber
 will not, directly or through any affiliate or person acting in concert with Subscriber,
 (i) create the lowest reported sales price on the NASDAQ National Market, (or other exchange
 or market if the Securities are traded thereon) for the common stock of the Company on any
 trading day or (ii) offer to sell shares of such common stock at a price lower than the then
 prevailing bid price for the common stock on such market.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(q) Subscriber
 hereby agrees to indemnify and hold harmless the Company, its directors, officers, agents,
 representatives, and each of their affiliates against any and all loss, liability, claim,
 damage and expense (including reasonable fees of attorneys and experts) as incurred, but
 only with respect to untrue statements or omissions, or alleged untrue statements or omissions,
 made in the Registration Statement (or any amendment thereto), in reliance upon and in conformity
 with information furnished to the Company by Subscriber.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(r) Subscriber
 acknowledges and understands that the Securities (and any security issuable upon the exercise
 of any Warrant) has not been registered for sale to the public under the Securities Act of
 1933, as amended (the "Securities Act"), or the laws of any state or other jurisdiction.
 The Subscriber understands that the Securities (and any security issuable upon the exercise
 of any Warrant) to be acquired by the Subscriber has not been registered under the Securities
 Act in reliance on an exemption thereunder for transactions not involving a public offering,
 and will not be so registered, and that at least a six month holding period shall apply to
 the Shares and the common stock of the Company issued pursuant to the exercise of any Warrant.
 The Subscriber acknowledges that the offer and sale the Securities (and any security issuable
 upon the exercise of any Warrant) to the Subscriber has not been accomplished by any form
 of general solicitation or general advertising, including, but not limited to, (i) any advertisement,
 article, notice or other communication published in any newspaper, magazine or similar media,
 or broadcast over television or radio, and (ii) any seminar or meeting whose attendees have
 been invited by any general solicitation or advertising. Subscriber shall not permit any
 other person to have a beneficial interest in the Subscriber's Securities (and any
 security issuable upon the exercise of any Warrant), and the Subscriber shall not sell, assign,
 transfer, convey, encumber, or otherwise dispose of all or any portion of the Subscriber's
 Membership Interest in the Company except in compliance with the registration requirements
 of the Securities Act and applicable state securities or "blue sky" laws .

C. <u>Company Representations and Warranties</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. The Company hereby represents and warrants to the Subscriber that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 Company is validly existing and in good standing under the laws of the State of Delaware
 and has all requisite corporate power and authority to enter into and to carry out and perform
 its obligations under this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) When
 issued and paid for on the date of closing, the Shares will be validly issued, fully paid
 and non-assessable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) When
 and if executed by the Company, this Agreement will have been duly authorized, validly executed,
 and delivered on behalf of the Company and will be a valid and binding agreement enforceable
 in accordance with its terms, subject to general principles of equity and to bankruptcy or
 other laws affecting the enforcement of creditors' rights generally.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) If
 this subscription is accepted by the Company, the Company will issue the Securities in the
 name of Subscriber. Nothing in this section shall affect in any way Subscriber's obligations
 and agreement to comply with all applicable securities laws upon resale of the Securities.

D. <u>Miscellaneous</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. This Agreement constitutes the entire understanding of the parties with regard to the subject matter, supersedes all written and oral agreements with respect to the same and may not be waived, modified, changed, discharged, terminated, revoked or canceled except by a writing signed by the party against which enforcement thereof is sought.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. Each party shall indemnify the other against any loss, cost or damages (including reasonable attorney's fees and expenses) incurred as a result of such parties' breach of any representation, warranty, or covenant contained in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. This Agreement shall be governed by and interpreted in accordance with the laws of the State of New York affecting contracts made in and to be performed in such State without giving effect to principles governing choice of laws, irrespective of the domicile of any party or the place of execution of this Agreement by any party or the location for performance of any of the terms hereof, and the parties hereto shall be subject to the exclusive jurisdiction of the state and federal courts located in Nassau County, New York, United States of America. Facsimile signatures to this Agreement or on any notice given hereunder shall be binding on all parties hereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. The Subscriber hereby certifies that Subscriber has read and understands this Subscription Agreement, that the representations and warranties made by the Subscriber in this Subscription Agreement are accurate on the date hereof, that Subscriber recognizes that the Company is relying on such representations and warranties and covenants and that they shall remain in effect through the closing of the sale of the Securities to Subscriber hereunder unless Subscriber notifies the Company otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. All notices required or permitted to be given by either the Company or the Subscriber pursuant to the terms of this Agreement shall be in writing and shall be deemed given when delivered personally or by facsimile, or by overnight or two day courier addressed to the parties at the last known address of the party or such other address as a party may request by notifying the other in writing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. The representations, warranties, covenants, indemnities, and agreements of the parties contained herein shall survive any termination or expiration of this Agreement.

IN WITNESS WHEREOF, the Subscriber has executed this Subscription Agreement as of the date above written.

---

| |
|:---|
| **INVESTOR** |
| **By:** |
| **Print Name:** |
| **Title:** |
| **Address:** |
| **Telephone:** |
| **Facsimile:** |
| **Number of Shares:** |

---

Accepted and Agreed To:

**RESEARCH FRONTIERS INCORPORATED**

By:   <br> Joseph M. Harary, President and CEO <br> Date of Acceptance: February __, 2026

Subscription Price Per Share (calculated pursuant to Section 1 hereof) $1.00/share.

## Exhibit 1.2

**Exhibit 1.2**

**[FORM OF WARRANT]**

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS THERE IS A REGISTRATION STATEMENT THEN IN EFFECT COVERING SUCH SECURITIES OR AN EFFECTIVE EXEMPTION FROM SUCH REGISTRATION OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT UNDER THE CIRCUMSTANCES REGISTRATION IS NOT NECESSARY.

**RESEARCH FRONTIERS INCORPORATED**

**COMMON STOCK PURCHASE WARRANT**

THIS CERTIFIES that, for value received, [INVESTOR], hereinafter called "Warrantholder"), is entitled to purchase from Research Frontiers Incorporated, a Delaware corporation (hereinafter called the "Company"), [NUMBER OF SHARES EQUAL TO NUMBER OF SHARES SUBSCRIBED FOR] shares of common stock, par value $.0001 per share (hereinafter called the "Shares") of the Company at a warrant exercise price equal to the Exercise Price per share (such price per share and the number of shares of common stock so purchasable being subject to adjustment as provided below) at any time on or before 4:30 p.m. New York time on February 28, 2031 (the "Expiration Date"), all in accordance with the terms hereof. The "Exercise Price" per share shall be $1.10 for warrant exercises occurring from the date of this Warrant Certificate through February 28, 2027, shall be $1.20 for warrant exercises occurring from March 1, 2027 through February 29, 2028, and shall be $1.30 for warrant exercises occurring from March 1, 2028 through February 28, 2029. For warrant exercises occurring after February 28, 2029, the Exercise Price per share shall be $1.50.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. <u>Exercise of Warrants and Holding of Underlying Stock.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1 The
 Warrants evidenced by this Warrant Certificate may be exercised at any time after September
 1, 2026 and prior to 4:30 p.m. New York time on the Expiration Date in whole at any time
 or in part from time to time during such period by the surrender of this Warrant Certificate,
 along with a Notice of Exercise in the form attached hereto duly executed and completed by
 Warrantholder, at the office of the Company, 240 Crossways Park Drive, Woodbury, New York
 11797-2033 together with payment in full in lawful money of the United States, of the Warrant
 exercise price payable at the time of such exercise in respect of the Warrants being exercised.
 Such payment shall be made by wire transfer of immediately available funds to the account
 of Research Frontiers Incorporated at JPMorgan Chase Bank, 6040 Tarbell Road, Syracuse, New
 York 13206, Account Number: 880-834-155, ABA Wire Code No.: 021 000 021, SWIFT CODE: CHASUS33,
 or to such other account or place, as the Company may specify.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2 Certificates representing Shares issued hereunder shall be stamped or otherwise imprinted with a legend substantially in the following form (in addition to any legend required under any applicable state securities laws):

THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS THERE IS A REGISTRATION STATEMENT THEN IN EFFECT COVERING SUCH SHARES OR AN EFFECTIVE EXEMPTION FROM SUCH REGISTRATION OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT UNDER THE CIRCUMSTANCES REGISTRATION IS NOT NECESSARY.

Provided, however, that if the issuance of the Shares pursuant to the exercise of this Warrant are subject to an effective registration statement pursuant to Section 5 of the Securities Act of 1933, as amended, certificates representing the Shares shall not bear any restrictive legend.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. <u>Reclassification, Consolidation or Merger</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1 In the event that the outstanding Shares are hereafter changed by reason of reorganization, merger, consolidation, recapitalization, reclassification, stock split-up, combination or exchange of Shares and the like, or dividends payable in Shares, an appropriate adjustment shall be made by the Board of Directors of the Company in the number of Shares and price per Share subject to this Warrant Certificate. If the Company shall be reorganized, consolidated, or merged with another corporation, or if all or substantially all of the assets of the Company shall be sold or exchanged, the Warrantholder shall at the time of issuance of the stock under such a corporate event, be entitled to receive upon the exercise of the vested Warrants evidenced by this Warrant Certificate the same number and kind of shares of stock or the same amount of property, cash or securities as he would have been entitled to receive upon the occurrence of any such corporate event as if he had been, immediately prior to such event, the holder of the number of Shares so exercised.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2 Any adjustment under this Paragraph 2 in the number of Shares subject to this Warrant Certificate shall apply proportionately to only the unexercised portion hereunder and shall not have any retroactive effect with respect to Warrants theretofore exercised. If fractions of a Share would result from any such adjustment, the adjustment shall be revised to the next lower whole number of Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3 No adjustment of the exercise price shall be made if the amount of such adjustment shall be less than $.01 per Share, but in such case any adjustment that would otherwise be required then to be made, shall be carried forward and shall be made at the time and together with the next subsequent adjustment which, together with any adjustment so carried forward, shall amount to no less than $.01 per share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4 No fractional shares of common stock shall be issued upon the exercise of any Warrants evidenced hereby, but in lieu thereof the number of shares of common stock that are issuable upon any exercise shall be rounded up or down to the nearest whole share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.5 When any adjustment is required to be made in the exercise price or number of Shares subject to this Warrant Certificate, initial or adjusted, the Company shall within sixty (60) days after the date when the circumstances giving rise to the adjustment occurred mail to the Warrantholder a statement describing in reasonable detail any method used in calculating such adjustment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.6 The undersigned Warrantholder agrees on behalf of itself or any of its affiliates that in the event the Company does not have an effective registration statement, there is no circumstance that would require the Company to net cash settle the Warrants subject to this Warrant Certificate or any warrants previously issued to the undersigned or any affiliate of the undersigned.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. <u>Prior Notice as to Certain Events.</u>

The Company shall mail to Warrantholder not less than ten (10) days prior to the date on which (a) a record will be taken for the purpose of determining the holders of Capital Stock entitled to subscription rights, or (b) a record will be taken (or in lieu thereof, the transfer books will be closed) for the purpose of determining the holders of Capital Stock entitled to notice of and to vote at the meeting of stockholders at which any consolidation, merger, dissolution, liquidation, winding up or sale of the Company shall be considered and acted upon.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. <u>Reservation and Issuance of Shares.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1 The Company covenants and agrees that all Shares which may be issued upon the exercise of the rights represented by this Warrant Certificate will be duly authorized, legally issued and when paid for in accordance with the terms hereof, fully paid and non-assessable, and free from all liens and charges with respect to the issue thereof to the Warrantholder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2 The Company will reserve at all times such number of Shares as may be issuable pursuant to the exercise of Warrants evidenced by this Warrant Certificate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. <u>Investment Representation</u>.

By accepting delivery of this Warrant Certificate and by exercising any Warrants evidenced hereby, the Warrantholder represents that the Warrantholder is acquiring the Warrants and the Shares issuable upon the exercise of the Warrants for investment and not for resale or distribution.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. <u>Miscellaneous.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1 The Warrantholder shall not be entitled to any rights whatsoever as a stockholder of the Company by virtue of its ownership of this Warrant Certificate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2 This Warrant Certificate is being executed and delivered in the State of New York, and this Warrant Certificate shall be interpreted under, and the Warrantholder and the Company subject to, the laws and jurisdiction of the state and federal courts of the State of New York, United States of America. The parties hereby consent to such jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3 Subject to the provisions of Section 1.2 hereof, this Warrant Certificate may be exercised at any time after the date hereof and prior to its expiration as of 4:30 p.m. New York time on the Expiration Date, and shall be void and of no effect after 4:30 p.m. New York time on the Expiration Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4 By accepting delivery of this Warrant Certificate, the Warrantholder acknowledges that the Warrants granted hereunder shall be in full satisfaction of all obligations to issue Warrants to the Warrantholder pursuant to the Subscription Agreement dated February 16, 2026 between the Company and the Warrantholder.

IN WITNESS WHEREOF, the Company and the Warrantholder have executed this Warrant Certificate this __ day of February, 2026 by each of their duly authorized officers.

---

| | |
|:---|:---|
| RESEARCH FRONTIERS INCORPORATED | RESEARCH FRONTIERS INCORPORATED |
| By: |  |
|  | Joseph M. Harary, President and CEO |
| WARRANTHOLDER: | WARRANTHOLDER: |
| [INVESTOR] | [INVESTOR] |
| By: |  |

---

[Form of Notice of Exercise]

The undersigned hereby irrevocably elects to exercise the warrants we currently hold to purchase ____________ shares of common stock, $0.0001 par value per share, of Research Frontiers Incorporated (the "Company") at an exercise price of $______ per share. Attached to this notice is the original Warrant certificate evidencing the aforementioned warrants. We have delivered to the Company US$_______________ representing the aggregate exercise price for the warrants exercised hereunder. A certificate representing the shares issuable upon exercise should be issued in the undersigned's name.

The undersigned hereby represents and warrants to the Company that the representations and warranties and acknowledgments made by the undersigned in the Subscription Agreement dated February 16, 2026 between the undersigned and the Company are still true and correct as if made on the date of this Notice of Exercise, and that the undersigned has carefully read any reports or statements filed with the Securities and Exchange Commission regarding the Company after the date of such Subscription Agreement, and that the Company has also made available to the undersigned all other documents and information that the undersigned has requested relating to an investment in the Company.

---

| | |
|:---|:---|
| Dated: | [INVESTOR] |
|  | By: |
|  | Name: |
|  | Title: |

---